Cytopia Limited (CYT.AX) Letter to Progen Industries Limited (PGLA) Shareholders
2/25/2009 9:50:08 AM
More...
|
Progen Industries Limited (PGLA)'s Phase 2 Liver Cancer Trial Exceeds Efficacy Objective
4/16/2007 12:42:46 PM
More...
|
Progen Industries Limited (PGLA) Files F-3 Shelf Registration with Securities and Exchange Commission
3/23/2007 9:40:31 AM
More...
|
Progen Industries Limited (PGLA) Buys Back PI-88 Royalty Obligation From Medigen Biotechnology Corporation
1/15/2007 7:25:25 PM
More...
|
FDA Provides Manufacturing Clearance For Progen Industries Limited (PGLAF)'s Phase III Trial Of Anti-Cancer Drug
11/29/2006 11:24:22 AM
More...
|
Progen Industries Limited (PGLAF) Prepares For Accelerated Clinical Development Of PI-88 Following FDA Meeting
5/16/2006 12:07:32 PM
More...
|
Progen Industries Limited (PGLAF) Meets With FDA To Progress PI-88 Clinical Development
3/27/2006 2:36:54 PM
More...
|
Progen Industries Limited (PGLAF) Half Yearly Financial Results
3/15/2006 1:45:40 PM
More...
|
Progen Industries Limited (PGLAF) Appoints New CEO
2/20/2006 10:52:27 AM
More...
|
Progen Industries Limited (PGLAF) Extends PI-88 Melanoma Clinical Program To First Line Treatment
10/19/2005 5:12:37 PM
More...
|
|